Active	Status	Sponsor type	Region	Phase	Filter
7 Active 14 Inactive 21 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gonzalez, Manuel
NCT03710460: Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in Obesity	Recruiting	4	33	RoW	Dapagliflozin, Forxiga, Dapagliflozin plus Metformin XR, XigDuo, Metformin XR	University of Guadalajara	Obesity	12/23	12/23
FALCON, NCT03918447 / 2018-004651-20: A Trial of Bardoxolone Methyl in Patients With ADPKD -	Terminated	3	667	Europe, Japan, US, RoW	Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule	Reata, a wholly owned subsidiary of Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC	Autosomal Dominant Polycystic Kidney, ADPKD	08/23	08/23
CAULE-IFACTOR, NCT04610021: Prospective i-FactorTM Analysis Fusion Rate and Quality of Life	Not yet recruiting	N/A	128	Europe	i-FactorTM Bone graft	Complejo Asistencial Universitario de León Urgencias	Spinal Deformity, Bone Graft, Fusion Rate, Quality of Life	03/24	03/27
EQUALITE, NCT06086990: Effects of Telemonitoring in Quality of Life Amongst Cancer Patients	Recruiting	N/A	80	RoW	Contigo Application	Universidad Nacional Andres Bello, Centro para la Prevención y Control del Cáncer (CECAN), Santiago, Chile	Cancer, Telemonitoring, Telemedicine, Symptoms and Signs, Quality of Life	12/24	03/25
Nervi, Bruno
NCT05119738: Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment	Recruiting	N/A	122	RoW	Three doses of BNT162b2 (observational), Two doses of Coronavac and one dose BNT162b2 (observational)	Pontificia Universidad Catolica de Chile	Sars-CoV-2 Infection	03/22	06/22
EQUALITE, NCT06086990: Effects of Telemonitoring in Quality of Life Amongst Cancer Patients	Recruiting	N/A	80	RoW	Contigo Application	Universidad Nacional Andres Bello, Centro para la Prevención y Control del Cáncer (CECAN), Santiago, Chile	Cancer, Telemonitoring, Telemedicine, Symptoms and Signs, Quality of Life	12/24	03/25
DETECT, NCT06077123: Telemonitoring Platforms and Chemotherapy-Associated Toxicity	Recruiting	N/A	80	RoW	Contigo Application	Universidad Nacional Andres Bello, Centro para la Prevención y Control del Cáncer (CECAN), Santiago, Chile	Cancer, Chemotherapeutic Agent Toxicity	12/24	03/25